Russian scientist, researcher and educator Dr. Mikhail Blagosklonny is a specialist on issues related to cancer and aging. For years the oncologist has studied the causes of and treatment for cancer, ways to address problems related to aging and the best methods to extend people’s lifespan. Dr. Blagosklonny has an M.D. in internal medicine from First Pavlov State Medical University located in St. Petersburg, Russia. He also has a PhD in cardiology and experimental medicine from the same university. Blagosklonny has also published numerous scholarly articles on aging and cancer. Visit ResearchGate to keep up to date with Mikhail’s latest work.
A well-respected and internationally known educator, Dr. Mikhail Blagosklonny began teaching medicine when the Valhalla, New York based New York Medical College hired him as an associate professor in 2002. Since then he has also worked as a senior scientist at Ordway Research Institute and an oncology professor at Roswell Park Cancer Institute for well over a decade. His research and teaching has been focused on cancer therapies, anti-aging drugs and the mechanisms underlying aging.
A prolific writer, Dr. Blagosklonny’s work has appeared in numerous peer-reviewed journals and he has had over 270 papers published. His more than 25,000 citations have resulted in him having an h-index of 83. Dr. Blagosklonny is also involved in publishing the work of other scientists, researchers and educators. He is editor-in-chief of the publications Aging, Oncotarget and Cell Cycle as well as associate editor of Cancer Biology & Therapy. Dr. Blagosklonny is also on the editorial board of Cell Death & Differentiation.
Dr. Blogosklonny’s vast amount of work related to cancer and aging has led him to come up with a unique hypothesis. He postulates that TOR signaling is involved in aging and cancer. Dr. Blagosklonny is also an internationally known passionate proponent of the use of the cancer drug rapamycin in life extension treatment and longevity research. His research related to cancer therapies have focused on identifying treatments that are able to destroy cancerous cells while protecting healthy cells from becoming damaged in the process. His knowledge and years of targeted research has enabled him to make many valuable contributions to the field. View Mikhail’s profile on Google Scholar.